Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 32801-32850 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06639451
A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)
NA
Recruiting
186 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2026
3 conditions
1 sponsor
8 locations
NCT06777433
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
PHASE2
Recruiting
30 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2026
1 condition
2 sponsors
5 locations
NCT06635889
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
PHASE2
Recruiting
116 participants
Started: Dec 13, 2024 · Completed: Oct 31, 2029
1 condition
1 sponsor
1 location
NCT06734000
Cohorte COSCINUS - Biocollection
N/A
Recruiting
105 participants
Started: Dec 13, 2024 · Completed: Oct 10, 2032
1 condition
1 sponsor
1 location
NCT06762366
Substitution Heuristic on Proportional Tasks
NA
Enrolling by invitation
220 participants
Started: Dec 13, 2024 · Completed: Mar 15, 2026
2 conditions
3 sponsors
1 location
NCT06008730
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
PHASE2
Recruiting
20 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06201234
Evaluating the Addition of Elacestrant (oral SERD) to Olaparib (PARP-inhibitor) in Patients with Advanced/metastatic HR+/HER2- Breast Cancer
PHASE2
Recruiting
176 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
4 conditions
2 sponsors
2 locations
NCT06657222
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
130 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
6 conditions
1 sponsor
13 locations
NCT06394830
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
PHASE2
Recruiting
50 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2025
2 conditions
2 sponsors
5 locations
NCT06557512
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NA
Recruiting
23 participants
Started: Dec 13, 2024 · Completed: Sep 30, 2029
3 conditions
2 sponsors
1 location
NCT06666764
Normobaric Oxygen in AIS Transferred for EVT
PHASE3
Recruiting
1,500 participants
Started: Dec 13, 2024 · Completed: Oct 31, 2027
1 condition
1 sponsor
2 locations
NCT06661577
An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
N/A
Not yet recruiting
3,000 participants
Started: Dec 13, 2024 · Completed: Feb 28, 2026
7 conditions
3 sponsors
2 locations
NCT06732141
Remote Anxiety Management for ICS-resistant Asthma Study
NA
Recruiting
216 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
4 locations
NCT06608927
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE3
Active, not recruiting
610 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2030
1 condition
2 sponsors
125 locations
NCT06829329
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
PHASE2
Active, not recruiting
105 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
4 locations
NCT06599931
Cerebello-motor Neuromodulation After Stroke. CERSTIM.
NA
Recruiting
45 participants
Started: Dec 13, 2024 · Completed: Dec 30, 2027
2 conditions
1 sponsor
2 locations
NCT06663072
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
PHASE1
Recruiting
25 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT06675955
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
PHASE3
Recruiting
500 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2029
1 condition
1 sponsor
21 locations
NCT06740266
The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families
NA
Recruiting
250 participants
Started: Dec 13, 2024 · Completed: Apr 30, 2029
4 conditions
3 sponsors
1 location
NCT06709040
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
N/A
Enrolling by invitation
500 participants
Started: Dec 13, 2024 · Completed: Apr 14, 2034
3 conditions
1 sponsor
1 location
NCT06696573
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
NA
Recruiting
180 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06736327
A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects with Advanced Solid Tumors
PHASE1
Recruiting
180 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06734832
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
PHASE3
Recruiting
8,000 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
4 locations
NCT06731530
Corneal Biomechanics, Optical Properties and Anterior Segment Structural Features in Patients With Pseudoexfoliation
N/A
Recruiting
86 participants
Started: Dec 13, 2024 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT06761092
Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
PHASE4
Active, not recruiting
72 participants
Started: Dec 13, 2024 · Completed: Feb 13, 2025
2 conditions
1 sponsor
1 location
NCT06764069
Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor
NA
Recruiting
10 participants
Started: Dec 13, 2024 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT06745557
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
PHASE3
Recruiting
70 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2028
1 condition
2 sponsors
1 location
NCT06441214
Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.
N/A
Recruiting
125 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
28 locations
NCT06740370
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
NA
Recruiting
32 participants
Started: Dec 13, 2024 · Completed: Aug 30, 2026
4 conditions
1 sponsor
1 location
NCT07125131
Gamification-Enhanced Problem-Based Learning
NA
Recruiting
100 participants
Started: Dec 13, 2024 · Completed: Feb 28, 2026
2 conditions
1 sponsor
1 location
NCT07066592
Investigation of the Effects of Prehabilitation Education Delivered Through a Mobile Compatible Website on Quality of Life and Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation
NA
Active, not recruiting
36 participants
Started: Dec 13, 2024 · Completed: Aug 15, 2025
3 conditions
2 sponsors
1 location
NCT05004233
Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplatelet Agent
NA
Recruiting
50 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT06921109
Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Migraines and Tension Type Headache
NA
Recruiting
60 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT06400069
Role of NLRP6 in Chronic Periodontitis
N/A
Recruiting
50 participants
Started: Dec 13, 2024 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT06690359
IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients
EARLY_PHASE1
Not yet recruiting
12 participants
Started: Dec 13, 2024 · Completed: Dec 20, 2026
2 conditions
1 sponsor
0 locations
NCT06463457
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)
PHASE2
Active, not recruiting
33 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2028
3 conditions
5 sponsors
3 locations
NCT06708468
Personalized Training for People With Rare Neuromuscular Disorders
NA
Recruiting
120 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
4 conditions
13 sponsors
5 locations
NCT06750432
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
PHASE1
Recruiting
128 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
22 locations
NCT06723184
Investigation of The Impact of Education Given to Grandmothers on Their Self-Confidence in Baby Care and Anxiety
NA
Not yet recruiting
48 participants
Started: Dec 13, 2024 · Completed: Oct 10, 2025
4 conditions
1 sponsor
1 location
NCT06527794
Remote Hypertension Management for Black Patients
NA
Recruiting
864 participants
Started: Dec 13, 2024 · Completed: Sep 30, 2028
1 condition
2 sponsors
1 location
NCT05988749
Digital Remote Home Monitoring for Heart Failure
NA
Enrolling by invitation
150 participants
Started: Dec 13, 2024 · Completed: Dec 2, 2025
1 condition
2 sponsors
2 locations
NCT06741085
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
PHASE2
Recruiting
56 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
8 locations
NCT06733792
A Mobile App to Reduce and/or Quit Cannabis Use
NA
Recruiting
120 participants
Started: Dec 13, 2024 · Completed: Mar 31, 2027
1 condition
2 sponsors
2 locations
NCT06271616
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
PHASE2
Recruiting
40 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06628310
A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
PHASE2
Recruiting
180 participants
Started: Dec 13, 2024 · Completed: Oct 31, 2030
3 conditions
1 sponsor
24 locations
NCT06526195
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NA
Recruiting
850 participants
Started: Dec 13, 2024 · Completed: Sep 30, 2032
4 conditions
1 sponsor
46 locations
NCT05373836
Relationship of PNI and Clinical Outcome in Patients Undergoing Brain Tumor Surgery
N/A
Not yet recruiting
5,000 participants
Started: Dec 12, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
NCT06964139
Hydrus Learning Curve Study
N/A
Active, not recruiting
5 participants
Started: Dec 12, 2024 · Completed: Jul 31, 2025
5 conditions
2 sponsors
1 location
NCT06636708
Efficacy of Nanodropper-mediated Topical Anesthetic
PHASE4
Recruiting
41 participants
Started: Dec 12, 2024 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT06584032
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
PHASE3
Recruiting
412 participants
Started: Dec 12, 2024 · Completed: Jun 9, 2029
1 condition
1 sponsor
17 locations
Previous
1
More pages
654
655
656
657
658
659
660
More pages
2369
Next